Merck & Co. currently faces about 1000 Fosamax lawsuits over their failure to adequately warn consumers and the medical community about the risk of a serious jawbone damage, known as osteonecrosis of the jaw, which causes portions of ...

Merck (NYSE: MRK) has lost its first Fosamax jury trial. A New York jury awarded $8 million in damages to plaintiff Shirley Boles, who claimed her osteonecrosis of the jaw was caused by the... Read more...

This Was A Retrial Of The First Fosamax MDL Case, Which Ended When Judge Declared Mistrial Back In September 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) The case of Boles v. Merck & Co., one of the hundreds of Fosamax jaw injury ...

The U.S. District Court jury in New York awarded that amount in compensatory damages to Shirley Boles, 72, of Fort Walton, Fla., who alleged Merck's Fosamax destroyed her jawbone near her ears, causing serious pain and disability. ...

Reuters is reporting that Merck's Fosamax generically known as alendronate may be among the bone drugs that carry such a risk.. Osteoporosis Drugs May Be Linked to Cancer Risk Health Buzz: Popular Osteoporosis Drugs Linked to Cancer ...

In replay of a courtroom battle that ended in a mistrial last fall, a federal jury today voted unanimously that Merck's Fosamax osteoporosis drug was responsible for causing jawbone deterioration suffered by a Florida woman, ...

The study covers a class of osteoporosis drugs called bisphosphonates, which are used to offset bone weakness. The drugs include Merck & Co's Fosamax, Roche's Boniva, Novartis's Reclast and Warner Chilcott's Actonel. ...

They include Merck & Co's Fosamax, Roche's Boniva, Novartis's Reclast and Warner Chilcott's Actonel. Green and colleagues from Britain's Medicines and Healthcare products Regulatory Agency (MHRA) analyzed data from the UK General ...

“Merck presented evidence that it acted appropriately in researching and developing Fosamax and in monitoring the medicine after it was placed on the market,” the company said in its statement today. Merck had Fosamax sales of $1.1 ...

Merck says it will appeal the decision. The case was brought by Shirley Boles of Fort Walton, Florida, who took Fosamax for about 10 years. Merck says her dental problems were due to heavy smoking and periodontal disease. ...